secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2022-12-21T23:59:59+00:00
Accession:  0001193125-22-310054
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin adopts amended bylaws with DGCL alignment and universal proxy rule updates
--------------------------------------------------------------------------------

- Board approved amended bylaws effective Dec 15, 2022, updating notice and meeting adjournment to align with DGCL.
- Requires stockholders soliciting proxies to use a proxy card color other than white.
- Amends procedural mechanics for stockholder nominations and proposals under SEC Rule 14a-19 (Universal Proxy Rules).
- Includes administrative, modernizing, and clarifying changes to the bylaws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000119312522310054/0001193125-22-310054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000119312522310054/d440213d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-310054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer